Desktop Site
|
24 Jul 24 | 10:59
|
Open
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
BSE SENSEX
80,275.39
-153.65
-0.19 %
Corporate Announcement
Security Code
506197
Company
BLISS GVS PHARMA LTD.
Exchange Received Time
17/07/2024 14:59:09
Exchange Disseminated Time
17/07/2024 14:59:10
Time Taken
00:00:01
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2024 |
7/17/2024 2:59:10 PM
BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2024 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2024. Further, according to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Internal Procedures and Conduct for Regulating, Monitoring, and Reporting of Trading by Designated Persons, the trading window for dealing in shares of the Company was closed for all the Designated Persons and their immediate relatives of the Company from July 01, 2024, and shall remain closed till 48 hours after the announcement/declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2024.
Attachment
<< Back
Recently Viewed